In Vitro Inhibition of Hepatitis C Virus by Antisense Oligonucleotides in PBMC Compared to Hepatoma Cells

Abstract EN

Aim.

To assess the efficiency of phosphorothioate antisense oligodeoxynucleotide 1 (S-ODN1) on HCV translation inhibition in PBMC compared to hepatoma cells in vitro for the first time.

Materials and Methods.

The study included 34 treatment naive HCV patients.

IRES domain III and IV sequence variations were tested in 45 clones from 9 HCV patients.

PBMC of HCV positive patients were subjected to S-ODN in vitro.

Concomitantly HepG2 cells infected by the same patient’s serum were also treated with S-ODN1 for 24 and 48 hours.

Cellular RNA was tested for HCV plus and minus strands by reverse transcription polymerase chain reaction (RT-PCR).

Results.

Sequence variations were seen in HCV IRES domain III only while domain IV was conserved among all the tested patient’s clones.

S-ODN1 successfully inhibited HCV translation in HepG2 cells, while in PBMC inhibition was partial.

Conclusion.

HCV IRES domain IV is more conserved than domain IIId in genotype 4 HCV patients.

S-ODN against HCV IRES domain IV was not efficient to inhibit HCV translation in PBMC under the study conditions.

Further studies testing other S-ODN targeting other HCV IRES domains in PBMC should be done.